ARCHIVES

Also HHS Inspector General is reviewing Lester Crawford’s departure from FDA.

This article is from The Cancer Letter archive.

Vol. 31 No. 39 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

FDA orders “limited distribution” for lung cancer drug Iressa.

June 24, 2005

Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL

June 11, 2014

Cooperative Group Massacre Hurt Some Of Best CCOPs Which May Go Unfunded

March 27, 1987

Clinical Trial Pathology Improvements Recommended By Group Remaining Actions After Merit Review

January 12, 1979

Targeted Biopsy More Effective At Selecting Men For Active Surveillance, Study Says

May 30, 2014

NCI Cooperative Group, Cancer Center Trials Listed

July 27, 2007